BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Structure Therapeutics Reports Second Quarter 2023 Financial Results and Recent Highlights

  Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases, today reported financial results for the second quarter June 30, 2023, and highlighted recent corporate achievements.

  August 10, 2023

   · 

  9 min read
• Business

  Teknova Reports Second Quarter 2023 Financial Results

  Alpha Teknova, Inc., a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, announced financial results for the second quarter ended June 30, 2023.

  August 10, 2023

   · 

  14 min read
• Business

  Sientra Reports Record Second Quarter Financial and Operational Results

  Sientra, Inc., a surgical aesthetics company developing the safest and most innovative solutions for the best aesthetic outcomes, announced its financial results for the second quarter that ended June 30, 2023.

  August 10, 2023

   · 

  18 min read
• Business

  Telesis Bio Reports Second Quarter 2023 Financial Results

  Telesis Bio Inc., a leader in automated multi-omic and synthetic biology solutions, reported financial results for the second quarter of 2023.

  August 10, 2023

   · 

  7 min read
• Business

  Eyenovia Reports Second Quarter 2023 Financial Results and Provides Business Update

  Eyenovia, Inc. announced its financial and operating results for the second quarter ended June 30, 2023.

  August 10, 2023

   · 

  11 min read
• Business

  CymaBay Reports Second Quarter and Six Months Ended June 30, 2023 Financial Results and Provides Corporate Update

  CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, announced corporate updates and financial results for the second quarter ended June 30, 2023.

  August 10, 2023

   · 

  9 min read
• Business

  Zymeworks Provides Corporate Update and Reports Second Quarter 2023 Financial Results

  Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel multifunctional biotherapeutics, today reported financial results for the three and six months ended June 30, 2023 and provided a summary of recent business highlights.

  August 10, 2023

   · 

  22 min read
• Business

  Helius Medical Technologies, Inc. Reports Second Quarter 2023 Financial Results

  Helius Medical Technologies, Inc., a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced results for the quarter ended June 30, 2023.

  August 10, 2023

   · 

  11 min read
• Business

  Spero Therapeutics Announces Second Quarter 2023 Operating Results and Provides a Business Update

  Spero Therapeutics, Inc. (Nasdaq: SPRO) announced today financial results for the second quarter ended June 30, 2023, and provided a business update.

  August 10, 2023

   · 

  12 min read
• Business

  Asensus Surgical, Inc. Reports Operating and Financial Results for the Second Quarter 2023

  Asensus Surgical, Inc. (“the Company”) (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the second quarter 2023.

  August 10, 2023

   · 

  15 min read